Page last updated: 2024-10-31

mianserin and Miosis

mianserin has been researched along with Miosis in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Miosis: Pupillary constriction. This may result from congenital absence of the dilatator pupillary muscle, defective sympathetic innervation, or irritation of the CONJUNCTIVA or CORNEA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Langford, NJ1
Ferner, RE1
Patel, H1
Munyame, C1
Hamlyn, AN1

Other Studies

1 other study available for mianserin and Miosis

ArticleYear
Mirtazepine overdose and miosis.
    Journal of toxicology. Clinical toxicology, 2003, Volume: 41, Issue:7

    Topics: Adult; Antidepressive Agents, Tricyclic; Drug Overdose; Female; Humans; Mianserin; Miosis; Mirtazapi

2003